Read the original: argenx raises $1.1 billion in gross proceeds in a global offering
Read the original: argenx raises $1.1 billion in gross proceeds in a global offering
Read more here: Santhera Announces Closing of Exclusive North America License Agreement with Catalyst Pharmaceuticals for Vamorolone
See the rest here: Nicox Provides Second Quarter 2023 Financial and Business Highlights
The rest is here: MeMed: FDA Clears Pioneering MeMed BV Test Direct From Whole Blood Allowing Faster Time To Result And Broader Patient Access When Distinguishing...
Autologous Stem Cell Based Therapies Market Analysis, Research ...
Stem Cell Banking Market Expected To Reach $16.55 Billion by 2030 | CAGR of 15.6% openPR
Calidi Biotherapeutics and City of Hope Announce First Patient ... BioSpace
Rejuvenation Biotechnology: The Quest to Reverse Aging Mirage News
BioLineRx Announces Initiation of Randomized Phase 2 Clinical ... PR Newswire
Recent Comments